Drugs / Crystalline Calcium Carbonate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06547151 Comparator | Dec 2024 → Sep 2026 overdue | hypoparathyroidism | Amorphical Ltd. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Crystalline Calcium Carbonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06547151 ↗ |
| Known as | CCC | “Control arm: Crystalline Calcium Carbonate (CCC) oral tablet contains 500 mg elemental calcium.” NCT06547151 ↗ |
| Route | Oral | “Control arm: Crystalline Calcium Carbonate (CCC) oral tablet contains 500 mg elemental calcium.” NCT06547151 ↗ |